

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 9.17791101 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 7.87523355 |
| 3 | lymphangiogenesis (GO:0001946) | 6.83982992 |
| 4 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 6.16222559 |
| 5 | endothelium development (GO:0003158) | 5.04800999 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 5.02662080 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.02662080 |
| 8 | cardiac myofibril assembly (GO:0055003) | 4.97634804 |
| 9 | positive regulation of protein kinase C signaling (GO:0090037) | 4.64035262 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.56484724 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.56484724 |
| 12 | artery smooth muscle contraction (GO:0014824) | 4.50939266 |
| 13 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.44934341 |
| 14 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.39840207 |
| 15 | heart trabecula formation (GO:0060347) | 4.35045838 |
| 16 | transcytosis (GO:0045056) | 4.34294402 |
| 17 | interleukin-6-mediated signaling pathway (GO:0070102) | 4.23438635 |
| 18 | myofibril assembly (GO:0030239) | 4.22807942 |
| 19 | tonic smooth muscle contraction (GO:0014820) | 4.22554803 |
| 20 | sarcomere organization (GO:0045214) | 4.17550512 |
| 21 | cell migration involved in heart development (GO:0060973) | 4.11491466 |
| 22 | positive regulation of astrocyte differentiation (GO:0048711) | 3.99670839 |
| 23 | regulation of protein activation cascade (GO:2000257) | 3.79446382 |
| 24 | exogenous drug catabolic process (GO:0042738) | 3.79413504 |
| 25 | epoxygenase P450 pathway (GO:0019373) | 3.72945951 |
| 26 | regulation of cholesterol esterification (GO:0010872) | 3.72445119 |
| 27 | atrioventricular valve morphogenesis (GO:0003181) | 3.70299156 |
| 28 | complement activation, alternative pathway (GO:0006957) | 3.70074753 |
| 29 | drug catabolic process (GO:0042737) | 3.69858522 |
| 30 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.68185949 |
| 31 | ethanol oxidation (GO:0006069) | 3.63971487 |
| 32 | regulation of sequestering of triglyceride (GO:0010889) | 3.62483030 |
| 33 | regulation of complement activation (GO:0030449) | 3.61179684 |
| 34 | glyoxylate metabolic process (GO:0046487) | 3.59346626 |
| 35 | glomerular filtration (GO:0003094) | 3.58825300 |
| 36 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.57001460 |
| 37 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.53734868 |
| 38 | omega-hydroxylase P450 pathway (GO:0097267) | 3.52215402 |
| 39 | protein heterotrimerization (GO:0070208) | 3.50545253 |
| 40 | plasma membrane repair (GO:0001778) | 3.44413752 |
| 41 | carnitine shuttle (GO:0006853) | 3.44087663 |
| 42 | fatty acid transmembrane transport (GO:1902001) | 3.43782101 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 3.42805496 |
| 44 | * potassium ion import (GO:0010107) | 3.40215647 |
| 45 | vascular smooth muscle contraction (GO:0014829) | 3.40175320 |
| 46 | aromatic amino acid family catabolic process (GO:0009074) | 3.36426147 |
| 47 | blood vessel endothelial cell migration (GO:0043534) | 3.35750012 |
| 48 | actin-myosin filament sliding (GO:0033275) | 3.35744893 |
| 49 | muscle filament sliding (GO:0030049) | 3.35744893 |
| 50 | regulation of actin filament-based movement (GO:1903115) | 3.34925670 |
| 51 | leukocyte tethering or rolling (GO:0050901) | 3.34786609 |
| 52 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.34045222 |
| 53 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.32027722 |
| 54 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.30307447 |
| 55 | blood coagulation, intrinsic pathway (GO:0007597) | 3.27746584 |
| 56 | positive regulation of vasculogenesis (GO:2001214) | 3.25467452 |
| 57 | regulation of fibrinolysis (GO:0051917) | 3.25302683 |
| 58 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.25100160 |
| 59 | triglyceride homeostasis (GO:0070328) | 3.23609418 |
| 60 | acylglycerol homeostasis (GO:0055090) | 3.23609418 |
| 61 | xenobiotic catabolic process (GO:0042178) | 3.22497901 |
| 62 | positive regulation of fatty acid oxidation (GO:0046321) | 3.21555949 |
| 63 | patterning of blood vessels (GO:0001569) | 3.21158880 |
| 64 | cGMP-mediated signaling (GO:0019934) | 3.19094374 |
| 65 | tricarboxylic acid cycle (GO:0006099) | 3.16791317 |
| 66 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.15066281 |
| 67 | endocardial cushion morphogenesis (GO:0003203) | 3.14303739 |
| 68 | renal filtration (GO:0097205) | 3.14168801 |
| 69 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.13515929 |
| 70 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.13468959 |
| 71 | sprouting angiogenesis (GO:0002040) | 3.12163057 |
| 72 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.12132487 |
| 73 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.11050798 |
| 74 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.08715790 |
| 75 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.08467953 |
| 76 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.07961980 |
| 77 | relaxation of smooth muscle (GO:0044557) | 3.07653852 |
| 78 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.05648096 |
| 79 | protein carboxylation (GO:0018214) | 3.05648096 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05072507 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.05072507 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.05072507 |
| 83 | trabecula formation (GO:0060343) | 3.04639675 |
| 84 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.02278842 |
| 85 | cardiac muscle contraction (GO:0060048) | 3.01865371 |
| 86 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.01219425 |
| 87 | drug metabolic process (GO:0017144) | 2.98982318 |
| 88 | bile acid biosynthetic process (GO:0006699) | 2.98860751 |
| 89 | negative regulation of protein activation cascade (GO:2000258) | 2.98343555 |
| 90 | phenylpropanoid metabolic process (GO:0009698) | 2.97689236 |
| 91 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.97583350 |
| 92 | regulation of fatty acid oxidation (GO:0046320) | 2.97188530 |
| 93 | surfactant homeostasis (GO:0043129) | 2.97134549 |
| 94 | actomyosin structure organization (GO:0031032) | 2.96945028 |
| 95 | cardiac muscle cell development (GO:0055013) | 2.96789315 |
| 96 | ketone body metabolic process (GO:1902224) | 2.95667790 |
| 97 | regulation of skeletal muscle contraction (GO:0014819) | 2.95602140 |
| 98 | regulation of phospholipase A2 activity (GO:0032429) | 2.95566153 |
| 99 | cardiac muscle cell proliferation (GO:0060038) | 2.95464763 |
| 100 | endothelial cell differentiation (GO:0045446) | 2.95450354 |
| 101 | regulation of vasculogenesis (GO:2001212) | 2.94796267 |
| 102 | sexual reproduction (GO:0019953) | 2.93660097 |
| 103 | basement membrane organization (GO:0071711) | 2.93346083 |
| 104 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.87221710 |
| 105 | regulation of endothelial cell differentiation (GO:0045601) | 2.85504208 |
| 106 | muscle tissue morphogenesis (GO:0060415) | 2.85318314 |
| 107 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.83713137 |
| 108 | cardiac cell development (GO:0055006) | 2.83702936 |
| 109 | regulation of lipoprotein metabolic process (GO:0050746) | 2.83518527 |
| 110 | oxidative demethylation (GO:0070989) | 2.82627013 |
| 111 | actin-mediated cell contraction (GO:0070252) | 2.82262870 |
| 112 | regulation of relaxation of muscle (GO:1901077) | 2.82212216 |
| 113 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.81110196 |
| 114 | positive regulation of muscle hypertrophy (GO:0014742) | 2.81110196 |
| 115 | lysine catabolic process (GO:0006554) | 2.77708469 |
| 116 | lysine metabolic process (GO:0006553) | 2.77708469 |
| 117 | mesenchyme morphogenesis (GO:0072132) | 2.76427941 |
| 118 | regulation of triglyceride catabolic process (GO:0010896) | 2.76127611 |
| 119 | striated muscle hypertrophy (GO:0014897) | 2.76055035 |
| 120 | fatty acid beta-oxidation (GO:0006635) | 2.74514611 |
| 121 | substrate-dependent cell migration (GO:0006929) | 2.73094949 |
| 122 | detection of calcium ion (GO:0005513) | 2.72486066 |
| 123 | 2-oxoglutarate metabolic process (GO:0006103) | 2.70811601 |
| 124 | ethanol metabolic process (GO:0006067) | 2.70691140 |
| 125 | endothelial tube morphogenesis (GO:0061154) | 2.69371263 |
| 126 | morphogenesis of an endothelium (GO:0003159) | 2.69371263 |
| 127 | embryonic heart tube development (GO:0035050) | 2.68933025 |
| 128 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.68777761 |
| 129 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.68641651 |
| 130 | negative regulation of fibrinolysis (GO:0051918) | 2.68156559 |
| 131 | gap junction assembly (GO:0016264) | 2.68062339 |
| 132 | cellular glucuronidation (GO:0052695) | 2.67738643 |
| 133 | negative regulation of complement activation (GO:0045916) | 2.66850291 |
| 134 | venous blood vessel morphogenesis (GO:0048845) | 2.66303180 |
| 135 | mesenchymal cell development (GO:0014031) | 2.65330012 |
| 136 | muscle cell proliferation (GO:0033002) | 2.64478619 |
| 137 | negative regulation of endothelial cell migration (GO:0010596) | 2.64331175 |
| 138 | negative regulation of platelet activation (GO:0010544) | 2.63901365 |
| 139 | positive regulation of endothelial cell proliferation (GO:0001938) | 2.62399049 |
| 140 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.61667575 |
| 141 | cell proliferation involved in metanephros development (GO:0072203) | 2.61276062 |
| 142 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.61203161 |
| 143 | high-density lipoprotein particle remodeling (GO:0034375) | 2.61056653 |
| 144 | relaxation of muscle (GO:0090075) | 2.59803458 |
| 145 | serine family amino acid catabolic process (GO:0009071) | 2.59087637 |
| 146 | regulation of cell communication by electrical coupling (GO:0010649) | 2.57940357 |
| 147 | carnitine transmembrane transport (GO:1902603) | 2.56656859 |
| 148 | creatine metabolic process (GO:0006600) | 2.52243460 |
| 149 | endothelial cell morphogenesis (GO:0001886) | 2.50960119 |
| 150 | glucuronate metabolic process (GO:0019585) | 2.50695200 |
| 151 | uronic acid metabolic process (GO:0006063) | 2.50695200 |
| 152 | negative regulation of lipase activity (GO:0060192) | 2.50075441 |
| 153 | cardiac muscle hypertrophy (GO:0003300) | 2.49643574 |
| 154 | reverse cholesterol transport (GO:0043691) | 2.49044040 |
| 155 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.49037499 |
| 156 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.48932221 |
| 157 | negative regulation of vascular permeability (GO:0043116) | 2.48728387 |
| 158 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.48609474 |
| 159 | fatty acid oxidation (GO:0019395) | 2.47991606 |
| 160 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.47298192 |
| 161 | S-adenosylmethionine metabolic process (GO:0046500) | 2.46910596 |
| 162 | phospholipid homeostasis (GO:0055091) | 2.46064169 |
| 163 | kidney mesenchyme development (GO:0072074) | 2.45058384 |
| 164 | relaxation of cardiac muscle (GO:0055119) | 2.44778775 |
| 165 | protein activation cascade (GO:0072376) | 2.44363656 |
| 166 | tyrosine metabolic process (GO:0006570) | 2.44260224 |
| 167 | regulation of lipoprotein lipase activity (GO:0051004) | 2.43823038 |
| 168 | regulation of plasminogen activation (GO:0010755) | 2.42501176 |
| 169 | cellular response to leptin stimulus (GO:0044320) | 2.42072883 |
| 170 | muscle hypertrophy (GO:0014896) | 2.40639750 |
| 171 | negative regulation of blood coagulation (GO:0030195) | 2.40155950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.48593821 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.96675791 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.44361812 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.58056443 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.27656914 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.84825271 |
| 7 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.66320249 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.62415932 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.48342314 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48274797 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35369606 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.33583674 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.28587179 |
| 14 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.22168784 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.22080243 |
| 16 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.20447920 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.16835029 |
| 18 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.15916529 |
| 19 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.15916529 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15341143 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.11718527 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11459315 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.11031085 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.06390578 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.96215572 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.93729687 |
| 27 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.84295399 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.82787574 |
| 29 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.81738226 |
| 30 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.80961622 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73985054 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72238066 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70435356 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.70292663 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67222152 |
| 36 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.66492541 |
| 37 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.65642198 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61671108 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60519403 |
| 40 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.60048308 |
| 41 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.60048308 |
| 42 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.60048308 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57228998 |
| 44 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55462869 |
| 45 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.54990517 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.54394478 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.52916333 |
| 48 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51477913 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51011691 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49596307 |
| 51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.49265960 |
| 52 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48257273 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48115167 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45014215 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43844309 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38564537 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37951083 |
| 58 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.37177386 |
| 59 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36298021 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35226694 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.34418780 |
| 62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.33978861 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31608411 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30192533 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28432527 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27192664 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27022957 |
| 68 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.26807356 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25516039 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25490938 |
| 71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23769885 |
| 72 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23563835 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22358852 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22061319 |
| 75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21987964 |
| 76 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.21231809 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.21231809 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19366399 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17461415 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17384812 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15912897 |
| 82 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.15423346 |
| 83 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14508553 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14161847 |
| 85 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.13973803 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13173515 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12696474 |
| 88 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.12342504 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11091253 |
| 90 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11006155 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10140452 |
| 92 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07204014 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07202534 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04009871 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03848348 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03408553 |
| 97 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.03208525 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03047776 |
| 99 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.02204821 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01043144 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00657300 |
| 102 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00618361 |
| 103 | TBL1_22424771_ChIP-Seq_293T_Human | 0.99823165 |
| 104 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99406744 |
| 105 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99395212 |
| 106 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99183808 |
| 107 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99124240 |
| 108 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98634791 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98102484 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98102484 |
| 111 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97979427 |
| 112 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97816952 |
| 113 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97140148 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96728166 |
| 115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96018202 |
| 116 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.94963774 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94448321 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93877387 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93267097 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92915122 |
| 121 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.92743155 |
| 122 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92375528 |
| 123 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92351234 |
| 124 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.91973348 |
| 125 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.91789848 |
| 126 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90778720 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.90750691 |
| 128 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.90612142 |
| 129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90005307 |
| 130 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89761683 |
| 131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89737274 |
| 132 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89348517 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89166642 |
| 134 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88653526 |
| 135 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.87781731 |
| 136 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.87748747 |
| 137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.87736130 |
| 138 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.87485647 |
| 139 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87386655 |
| 140 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87271095 |
| 141 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86721197 |
| 142 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86084723 |
| 143 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85177882 |
| 144 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84355776 |
| 145 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84320193 |
| 146 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.83564335 |
| 147 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.82693726 |
| 148 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.82656575 |
| 149 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82351979 |
| 150 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.82217625 |
| 151 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81383125 |
| 152 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80630444 |
| 153 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.80256938 |
| 154 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.79977411 |
| 155 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79643844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 6.10079533 |
| 2 | MP0006054_spinal_hemorrhage | 4.95392109 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 4.82064845 |
| 4 | MP0003724_increased_susceptibility_to | 4.04946825 |
| 5 | MP0000013_abnormal_adipose_tissue | 3.85720619 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.84491700 |
| 7 | MP0003283_abnormal_digestive_organ | 3.46101679 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.45784588 |
| 9 | * MP0004215_abnormal_myocardial_fiber | 3.12177499 |
| 10 | MP0004084_abnormal_cardiac_muscle | 3.10634494 |
| 11 | MP0004272_abnormal_basement_membrane | 2.91382136 |
| 12 | MP0000751_myopathy | 2.84505963 |
| 13 | MP0004130_abnormal_muscle_cell | 2.83577272 |
| 14 | MP0008004_abnormal_stomach_pH | 2.82978898 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.61092689 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.37769042 |
| 17 | MP0004036_abnormal_muscle_relaxation | 2.35621122 |
| 18 | MP0005330_cardiomyopathy | 2.28213455 |
| 19 | MP0003279_aneurysm | 2.16216992 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.10214281 |
| 21 | MP0005187_abnormal_penis_morphology | 2.04638395 |
| 22 | MP0003195_calcinosis | 2.00861266 |
| 23 | MP0005670_abnormal_white_adipose | 1.99213305 |
| 24 | MP0003646_muscle_fatigue | 1.97513960 |
| 25 | MP0000003_abnormal_adipose_tissue | 1.95659351 |
| 26 | MP0003828_pulmonary_edema | 1.94504345 |
| 27 | MP0002972_abnormal_cardiac_muscle | 1.94140451 |
| 28 | MP0005620_abnormal_muscle_contractility | 1.93734543 |
| 29 | MP0008775_abnormal_heart_ventricle | 1.78222048 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.78214668 |
| 31 | MP0000749_muscle_degeneration | 1.77409105 |
| 32 | MP0003868_abnormal_feces_composition | 1.77265503 |
| 33 | MP0002638_abnormal_pupillary_reflex | 1.76656595 |
| 34 | MP0003137_abnormal_impulse_conducting | 1.72724742 |
| 35 | MP0010630_abnormal_cardiac_muscle | 1.67161540 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.65627860 |
| 37 | MP0005385_cardiovascular_system_phenoty | 1.64318116 |
| 38 | MP0001544_abnormal_cardiovascular_syste | 1.64318116 |
| 39 | MP0004087_abnormal_muscle_fiber | 1.63734534 |
| 40 | MP0006138_congestive_heart_failure | 1.63239318 |
| 41 | MP0005332_abnormal_amino_acid | 1.61990527 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.56586422 |
| 43 | MP0004484_altered_response_of | 1.54438435 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.52468850 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.51945535 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49886247 |
| 47 | MP0002127_abnormal_cardiovascular_syste | 1.49609038 |
| 48 | MP0001851_eye_inflammation | 1.43474023 |
| 49 | MP0000750_abnormal_muscle_regeneration | 1.43337885 |
| 50 | MP0005165_increased_susceptibility_to | 1.43179348 |
| 51 | MP0009840_abnormal_foam_cell | 1.42277073 |
| 52 | MP0000767_abnormal_smooth_muscle | 1.42038378 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.36611876 |
| 54 | MP0003136_yellow_coat_color | 1.35970360 |
| 55 | MP0005275_abnormal_skin_tensile | 1.34113094 |
| 56 | MP0000343_altered_response_to | 1.33136586 |
| 57 | MP0005623_abnormal_meninges_morphology | 1.29647098 |
| 58 | * MP0004085_abnormal_heartbeat | 1.28061340 |
| 59 | MP0009697_abnormal_copulation | 1.27296455 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.27177409 |
| 61 | MP0004019_abnormal_vitamin_homeostasis | 1.25925692 |
| 62 | MP0003252_abnormal_bile_duct | 1.25594902 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.25338343 |
| 64 | MP0002128_abnormal_blood_circulation | 1.25329509 |
| 65 | MP0005595_abnormal_vascular_smooth | 1.24542988 |
| 66 | MP0000230_abnormal_systemic_arterial | 1.12819155 |
| 67 | MP0002106_abnormal_muscle_physiology | 1.11433699 |
| 68 | MP0005164_abnormal_response_to | 1.11038653 |
| 69 | MP0004147_increased_porphyrin_level | 1.09417056 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 1.06878636 |
| 71 | MP0004145_abnormal_muscle_electrophysio | 1.03004776 |
| 72 | MP0002163_abnormal_gland_morphology | 1.01344163 |
| 73 | MP0001661_extended_life_span | 1.01212759 |
| 74 | MP0005085_abnormal_gallbladder_physiolo | 1.00777278 |
| 75 | MP0001944_abnormal_pancreas_morphology | 1.00647912 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.99407769 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.99219076 |
| 78 | MP0005409_darkened_coat_color | 0.97891757 |
| 79 | MP0000462_abnormal_digestive_system | 0.96347166 |
| 80 | MP0000249_abnormal_blood_vessel | 0.95372129 |
| 81 | MP0000266_abnormal_heart_morphology | 0.95063024 |
| 82 | MP0010329_abnormal_lipoprotein_level | 0.94432818 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.93699787 |
| 84 | MP0002269_muscular_atrophy | 0.93407938 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.93233682 |
| 86 | MP0005369_muscle_phenotype | 0.92838053 |
| 87 | MP0005360_urolithiasis | 0.92788080 |
| 88 | MP0009384_cardiac_valve_regurgitation | 0.91807106 |
| 89 | MP0000516_abnormal_urinary_system | 0.91443604 |
| 90 | MP0005367_renal/urinary_system_phenotyp | 0.91443604 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.91076674 |
| 92 | MP0000747_muscle_weakness | 0.91044292 |
| 93 | MP0003879_abnormal_hair_cell | 0.90937371 |
| 94 | MP0003705_abnormal_hypodermis_morpholog | 0.90555514 |
| 95 | MP0001614_abnormal_blood_vessel | 0.89593336 |
| 96 | MP0005646_abnormal_pituitary_gland | 0.88672810 |
| 97 | MP0001958_emphysema | 0.87837870 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.87663311 |
| 99 | MP0002295_abnormal_pulmonary_circulatio | 0.87364007 |
| 100 | MP0002925_abnormal_cardiovascular_devel | 0.87125183 |
| 101 | MP0000759_abnormal_skeletal_muscle | 0.86882144 |
| 102 | MP0003186_abnormal_redox_activity | 0.84869314 |
| 103 | MP0001873_stomach_inflammation | 0.83567413 |
| 104 | MP0002166_altered_tumor_susceptibility | 0.82048800 |
| 105 | MP0009278_abnormal_bone_marrow | 0.81633382 |
| 106 | MP0003303_peritoneal_inflammation | 0.79585306 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.78297946 |
| 108 | MP0003119_abnormal_digestive_system | 0.77947786 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.77167083 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.76226062 |
| 111 | MP0001756_abnormal_urination | 0.76221326 |
| 112 | MP0005448_abnormal_energy_balance | 0.75339632 |
| 113 | MP0001664_abnormal_digestion | 0.75070189 |
| 114 | MP0005365_abnormal_bile_salt | 0.72830652 |
| 115 | MP0001270_distended_abdomen | 0.71059493 |
| 116 | MP0005503_abnormal_tendon_morphology | 0.70530741 |
| 117 | MP0003011_delayed_dark_adaptation | 0.69312015 |
| 118 | MP0006072_abnormal_retinal_apoptosis | 0.68266471 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.68153718 |
| 120 | MP0005535_abnormal_body_temperature | 0.67805495 |
| 121 | MP0002108_abnormal_muscle_morphology | 0.67662044 |
| 122 | MP0002933_joint_inflammation | 0.64733402 |
| 123 | MP0001915_intracranial_hemorrhage | 0.64620041 |
| 124 | MP0004883_abnormal_blood_vessel | 0.64481238 |
| 125 | MP0003385_abnormal_body_wall | 0.64125861 |
| 126 | MP0003191_abnormal_cellular_cholesterol | 0.63609701 |
| 127 | MP0003950_abnormal_plasma_membrane | 0.60841478 |
| 128 | MP0001784_abnormal_fluid_regulation | 0.58586416 |
| 129 | MP0000609_abnormal_liver_physiology | 0.57580068 |
| 130 | MP0001243_abnormal_dermal_layer | 0.57520935 |
| 131 | MP0003091_abnormal_cell_migration | 0.57225327 |
| 132 | MP0001533_abnormal_skeleton_physiology | 0.56266917 |
| 133 | MP0008961_abnormal_basal_metabolism | 0.55827130 |
| 134 | * MP0009763_increased_sensitivity_to | 0.54520817 |
| 135 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54462414 |
| 136 | MP0002009_preneoplasia | 0.52698984 |
| 137 | MP0002971_abnormal_brown_adipose | 0.52622536 |
| 138 | MP0003045_fibrosis | 0.52248491 |
| 139 | MP0006036_abnormal_mitochondrial_physio | 0.51778590 |
| 140 | MP0004510_myositis | 0.51664653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nonimmune hydrops fetalis (HP:0001790) | 6.65391759 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.04568090 |
| 3 | Broad metatarsal (HP:0001783) | 6.04288036 |
| 4 | Hypoplastic ischia (HP:0003175) | 4.82959581 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.78191232 |
| 6 | Sudden death (HP:0001699) | 4.72437150 |
| 7 | Complement deficiency (HP:0004431) | 4.42621450 |
| 8 | Abnormality of the ischium (HP:0003174) | 4.35728940 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.33566660 |
| 10 | Muscle fiber splitting (HP:0003555) | 4.30320739 |
| 11 | Atrial fibrillation (HP:0005110) | 4.28326410 |
| 12 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 4.22978904 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.22046088 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.17405650 |
| 15 | Congenital, generalized hypertrichosis (HP:0004540) | 4.13905990 |
| 16 | Lipoatrophy (HP:0100578) | 3.99593785 |
| 17 | Primary atrial arrhythmia (HP:0001692) | 3.95955505 |
| 18 | Increased connective tissue (HP:0009025) | 3.95269109 |
| 19 | Supraventricular arrhythmia (HP:0005115) | 3.88655394 |
| 20 | Exercise-induced myalgia (HP:0003738) | 3.88160789 |
| 21 | Supraventricular tachycardia (HP:0004755) | 3.79477127 |
| 22 | Vascular calcification (HP:0004934) | 3.64533313 |
| 23 | Large for gestational age (HP:0001520) | 3.62313751 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 3.59945738 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 3.59625976 |
| 26 | Calf muscle hypertrophy (HP:0008981) | 3.59411154 |
| 27 | Lymphangioma (HP:0100764) | 3.53838018 |
| 28 | Mitral stenosis (HP:0001718) | 3.44522887 |
| 29 | Exercise-induced muscle cramps (HP:0003710) | 3.41406395 |
| 30 | Cardiovascular calcification (HP:0011915) | 3.39920165 |
| 31 | Aortic dissection (HP:0002647) | 3.39841704 |
| 32 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.27510359 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 3.21913360 |
| 34 | Type 1 muscle fiber predominance (HP:0003803) | 3.19392313 |
| 35 | Abnormality of complement system (HP:0005339) | 3.18745319 |
| 36 | Dilated cardiomyopathy (HP:0001644) | 3.12911966 |
| 37 | Premature rupture of membranes (HP:0001788) | 3.11260887 |
| 38 | Abnormality of the calf musculature (HP:0001430) | 3.10821755 |
| 39 | Myoglobinuria (HP:0002913) | 3.10648633 |
| 40 | Difficulty running (HP:0009046) | 3.07951795 |
| 41 | Polycythemia (HP:0001901) | 3.06576270 |
| 42 | Joint hemorrhage (HP:0005261) | 3.05583056 |
| 43 | * Short hallux (HP:0010109) | 3.03716194 |
| 44 | Aortic aneurysm (HP:0004942) | 3.02346536 |
| 45 | Bone cyst (HP:0012062) | 2.98912327 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.93419854 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.92778875 |
| 48 | Venous insufficiency (HP:0005293) | 2.87284214 |
| 49 | Deep venous thrombosis (HP:0002625) | 2.86592543 |
| 50 | Venous abnormality (HP:0002624) | 2.82367583 |
| 51 | * Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.80990283 |
| 52 | Syncope (HP:0001279) | 2.74462810 |
| 53 | Hypobetalipoproteinemia (HP:0003563) | 2.70024381 |
| 54 | Capillary hemangiomas (HP:0005306) | 2.69128746 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.65699626 |
| 56 | Lymphedema (HP:0001004) | 2.65672819 |
| 57 | Protrusio acetabuli (HP:0003179) | 2.64265885 |
| 58 | Xanthomatosis (HP:0000991) | 2.62448503 |
| 59 | EMG: myopathic abnormalities (HP:0003458) | 2.61535525 |
| 60 | Palpitations (HP:0001962) | 2.56949404 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 2.54099738 |
| 62 | Ketoacidosis (HP:0001993) | 2.51182318 |
| 63 | Ankle contracture (HP:0006466) | 2.48559750 |
| 64 | Bundle branch block (HP:0011710) | 2.46572368 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.45367770 |
| 66 | Bicuspid aortic valve (HP:0001647) | 2.44516739 |
| 67 | Facial diplegia (HP:0001349) | 2.40220035 |
| 68 | Aneurysm (HP:0002617) | 2.39503044 |
| 69 | Delayed CNS myelination (HP:0002188) | 2.39106296 |
| 70 | Rhabdomyolysis (HP:0003201) | 2.38040791 |
| 71 | Hematochezia (HP:0002573) | 2.37751304 |
| 72 | Asymmetric septal hypertrophy (HP:0001670) | 2.37716857 |
| 73 | Intrahepatic cholestasis (HP:0001406) | 2.36407576 |
| 74 | Left ventricular hypertrophy (HP:0001712) | 2.33823176 |
| 75 | Spontaneous abortion (HP:0005268) | 2.33074797 |
| 76 | Pheochromocytoma (HP:0002666) | 2.32877465 |
| 77 | Abnormality of the intrinsic pathway (HP:0010989) | 2.32515687 |
| 78 | Facial shape deformation (HP:0011334) | 2.32079101 |
| 79 | Potter facies (HP:0002009) | 2.32079101 |
| 80 | Prolonged QT interval (HP:0001657) | 2.31871461 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 2.31126543 |
| 82 | Glycosuria (HP:0003076) | 2.31126543 |
| 83 | Ulnar claw (HP:0001178) | 2.27125700 |
| 84 | Myotonia (HP:0002486) | 2.24931677 |
| 85 | Cerebral hemorrhage (HP:0001342) | 2.23907191 |
| 86 | Systemic lupus erythematosus (HP:0002725) | 2.23886486 |
| 87 | Chondrocalcinosis (HP:0000934) | 2.23689091 |
| 88 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.22624445 |
| 89 | Hypolipoproteinemia (HP:0010981) | 2.22601862 |
| 90 | Abnormality of the pubic bones (HP:0003172) | 2.22192776 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 2.18994551 |
| 92 | Muscle stiffness (HP:0003552) | 2.18604360 |
| 93 | Arthropathy (HP:0003040) | 2.17422308 |
| 94 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.16812476 |
| 95 | Subaortic stenosis (HP:0001682) | 2.16812476 |
| 96 | Ventricular arrhythmia (HP:0004308) | 2.16111289 |
| 97 | Esophageal varix (HP:0002040) | 2.14980233 |
| 98 | Glomerulonephritis (HP:0000099) | 2.13506101 |
| 99 | Axonal loss (HP:0003447) | 2.13277350 |
| 100 | Large hands (HP:0001176) | 2.12615428 |
| 101 | Heart block (HP:0012722) | 2.12352014 |
| 102 | Distal arthrogryposis (HP:0005684) | 2.11438425 |
| 103 | Abnormality of Sharpey fibers (HP:0100685) | 2.09934781 |
| 104 | Double outlet right ventricle (HP:0001719) | 2.08931566 |
| 105 | Congenital malformation of the right heart (HP:0011723) | 2.08931566 |
| 106 | * Prominent supraorbital ridges (HP:0000336) | 2.08182627 |
| 107 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07306718 |
| 108 | Steatorrhea (HP:0002570) | 2.07112669 |
| 109 | Atrioventricular block (HP:0001678) | 2.06735218 |
| 110 | Abnormal atrioventricular conduction (HP:0005150) | 2.05051075 |
| 111 | Hyperglycinemia (HP:0002154) | 2.03856171 |
| 112 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03586879 |
| 113 | Dicarboxylic aciduria (HP:0003215) | 2.03586879 |
| 114 | Hypoplastic left heart (HP:0004383) | 2.03583199 |
| 115 | Ketosis (HP:0001946) | 2.01864056 |
| 116 | Visceral angiomatosis (HP:0100761) | 2.01695843 |
| 117 | Round ear (HP:0100830) | 2.00655183 |
| 118 | Neuroendocrine neoplasm (HP:0100634) | 2.00579877 |
| 119 | Mesangial abnormality (HP:0001966) | 2.00366816 |
| 120 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00319056 |
| 121 | Fat malabsorption (HP:0002630) | 1.99270535 |
| 122 | Pulmonary artery stenosis (HP:0004415) | 1.95636500 |
| 123 | Scotoma (HP:0000575) | 1.95462591 |
| 124 | Difficulty climbing stairs (HP:0003551) | 1.95410053 |
| 125 | Stroke (HP:0001297) | 1.93867323 |
| 126 | Palpebral edema (HP:0100540) | 1.93634555 |
| 127 | Spinal rigidity (HP:0003306) | 1.92928459 |
| 128 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.91720068 |
| 129 | Broad hallux (HP:0010055) | 1.90494699 |
| 130 | Abnormality of the vitreous humor (HP:0004327) | 1.89909031 |
| 131 | Abnormal EKG (HP:0003115) | 1.87593670 |
| 132 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86460360 |
| 133 | Rimmed vacuoles (HP:0003805) | 1.86390319 |
| 134 | Congestive heart failure (HP:0001635) | 1.86036898 |
| 135 | Abnormality of the sella turcica (HP:0002679) | 1.85694498 |
| 136 | Hemangiomatosis (HP:0007461) | 1.85666407 |
| 137 | Toxemia of pregnancy (HP:0100603) | 1.84757283 |
| 138 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84046045 |
| 139 | Hemiparesis (HP:0001269) | 1.82000326 |
| 140 | Generalized aminoaciduria (HP:0002909) | 1.81901739 |
| 141 | Conjugated hyperbilirubinemia (HP:0002908) | 1.78832905 |
| 142 | Striae distensae (HP:0001065) | 1.78710062 |
| 143 | Abnormality of glycine metabolism (HP:0010895) | 1.76515708 |
| 144 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.76515708 |
| 145 | Muscle fiber inclusion bodies (HP:0100299) | 1.76294596 |
| 146 | Reduced antithrombin III activity (HP:0001976) | 1.75921076 |
| 147 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.75288648 |
| 148 | Nausea (HP:0002018) | 1.74276988 |
| 149 | Ventricular fibrillation (HP:0001663) | 1.74209585 |
| 150 | Testicular atrophy (HP:0000029) | 1.73446979 |
| 151 | Abnormality of the foot musculature (HP:0001436) | 1.71949009 |
| 152 | Skin nodule (HP:0200036) | 1.71326561 |
| 153 | Hyperammonemia (HP:0001987) | 1.69098692 |
| 154 | Hyperglycinuria (HP:0003108) | 1.68502378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.48412834 |
| 2 | TTN | 3.65051147 |
| 3 | MYLK | 3.55199437 |
| 4 | STK39 | 3.01091592 |
| 5 | TGFBR2 | 2.87788479 |
| 6 | PDGFRA | 2.12944249 |
| 7 | KDR | 10.1316430 |
| 8 | PNCK | 1.82532374 |
| 9 | ERN1 | 1.81158317 |
| 10 | DMPK | 1.73940016 |
| 11 | BMPR1B | 1.73776042 |
| 12 | LMTK2 | 1.73602752 |
| 13 | RIPK1 | 1.63079781 |
| 14 | NLK | 1.61546343 |
| 15 | MAP3K4 | 1.56775779 |
| 16 | PHKG1 | 1.52242385 |
| 17 | PHKG2 | 1.52242385 |
| 18 | TGFBR1 | 1.44611175 |
| 19 | OBSCN | 1.43974825 |
| 20 | TRIB3 | 1.43855665 |
| 21 | MAP3K6 | 1.43135648 |
| 22 | NTRK3 | 1.42907603 |
| 23 | JAK1 | 1.41677347 |
| 24 | EPHB2 | 1.36585044 |
| 25 | ACVR1B | 1.29318711 |
| 26 | PKN2 | 1.27493892 |
| 27 | PRKCE | 1.25745491 |
| 28 | KIT | 1.24639177 |
| 29 | MAP2K7 | 1.24432324 |
| 30 | BCKDK | 1.23140418 |
| 31 | PTK2B | 1.15733743 |
| 32 | CAMK4 | 1.13082279 |
| 33 | PRKG1 | 1.12141073 |
| 34 | MAP3K2 | 1.11770488 |
| 35 | PAK3 | 1.10355128 |
| 36 | PDK2 | 1.08087459 |
| 37 | PDK3 | 1.04892567 |
| 38 | PDK4 | 1.04892567 |
| 39 | MAPK12 | 1.01450568 |
| 40 | EPHB1 | 0.99398546 |
| 41 | JAK3 | 0.98704887 |
| 42 | ROCK2 | 0.94878952 |
| 43 | OXSR1 | 0.94632961 |
| 44 | CDK3 | 0.94096626 |
| 45 | GRK1 | 0.90568040 |
| 46 | DAPK2 | 0.87445745 |
| 47 | WNK4 | 0.86821387 |
| 48 | PTK6 | 0.86371970 |
| 49 | WNK3 | 0.86215280 |
| 50 | FGFR4 | 0.84434566 |
| 51 | LIMK1 | 0.82312586 |
| 52 | ADRBK2 | 0.81465939 |
| 53 | PIK3CA | 0.80896766 |
| 54 | RAF1 | 0.80776259 |
| 55 | MAP2K3 | 0.78668336 |
| 56 | JAK2 | 0.76026814 |
| 57 | AKT2 | 0.73897558 |
| 58 | SIK1 | 0.73445068 |
| 59 | PDGFRB | 0.73346597 |
| 60 | PAK2 | 0.73203848 |
| 61 | CAMK2G | 0.72720795 |
| 62 | CASK | 0.72281340 |
| 63 | NUAK1 | 0.72279249 |
| 64 | ROCK1 | 0.71428848 |
| 65 | FLT3 | 0.69320640 |
| 66 | FER | 0.68335191 |
| 67 | PRKACA | 0.67589563 |
| 68 | ITK | 0.67481356 |
| 69 | PRKD1 | 0.66711230 |
| 70 | SGK2 | 0.62999102 |
| 71 | PRKACG | 0.62927297 |
| 72 | PRKAA2 | 0.62868211 |
| 73 | NEK9 | 0.62144260 |
| 74 | MET | 0.62086455 |
| 75 | CAMK2B | 0.61389020 |
| 76 | STK4 | 0.61225012 |
| 77 | RET | 0.61012151 |
| 78 | MAP2K4 | 0.60679643 |
| 79 | FGFR2 | 0.57459218 |
| 80 | PKN1 | 0.56230581 |
| 81 | MAP2K1 | 0.55755141 |
| 82 | STK11 | 0.55431029 |
| 83 | DAPK3 | 0.54988927 |
| 84 | PTK2 | 0.54764871 |
| 85 | EPHA3 | 0.54082892 |
| 86 | EIF2AK3 | 0.54050378 |
| 87 | IRAK1 | 0.52428125 |
| 88 | MAP2K6 | 0.52295956 |
| 89 | CSK | 0.51753395 |
| 90 | PRKG2 | 0.51183954 |
| 91 | CDK9 | 0.50098974 |
| 92 | PRKCH | 0.49939451 |
| 93 | STK24 | 0.49038958 |
| 94 | MAPK15 | 0.48351387 |
| 95 | RPS6KA6 | 0.47860934 |
| 96 | RPS6KL1 | 0.46941257 |
| 97 | RPS6KC1 | 0.46941257 |
| 98 | CAMK1D | 0.46007848 |
| 99 | MAP3K7 | 0.45799345 |
| 100 | GRK7 | 0.45408088 |
| 101 | PRKCG | 0.45077367 |
| 102 | ILK | 0.44146560 |
| 103 | CDC42BPA | 0.43770509 |
| 104 | CCNB1 | 0.43658100 |
| 105 | MAP3K11 | 0.43391360 |
| 106 | SGK223 | 0.43275863 |
| 107 | SGK494 | 0.43275863 |
| 108 | PRKD2 | 0.43072778 |
| 109 | ABL2 | 0.42026322 |
| 110 | INSRR | 0.41961560 |
| 111 | CAMK1G | 0.37699647 |
| 112 | MAPK7 | 0.37266258 |
| 113 | MAPKAPK3 | 0.36322104 |
| 114 | PIK3CG | 0.36005964 |
| 115 | MAP3K3 | 0.35866288 |
| 116 | FGFR3 | 0.34638999 |
| 117 | TYK2 | 0.32646880 |
| 118 | LRRK2 | 0.31342222 |
| 119 | IGF1R | 0.31159795 |
| 120 | PRKAA1 | 0.30449545 |
| 121 | CAMK2A | 0.29901652 |
| 122 | TBK1 | 0.29398475 |
| 123 | GSK3A | 0.28031202 |
| 124 | NTRK1 | 0.27927878 |
| 125 | MAP2K2 | 0.27813313 |
| 126 | TAOK1 | 0.27551814 |
| 127 | MAP3K1 | 0.26817359 |
| 128 | SRC | 0.26800906 |
| 129 | INSR | 0.26237841 |
| 130 | MUSK | 0.25705504 |
| 131 | DDR2 | 0.25071185 |
| 132 | MAP3K10 | 0.25025363 |
| 133 | PINK1 | 0.24898685 |
| 134 | ADRBK1 | 0.23722888 |
| 135 | FRK | 0.22545891 |
| 136 | LATS1 | 0.22169375 |
| 137 | STK38 | 0.20776391 |
| 138 | CAMK1 | 0.20661238 |
| 139 | PRKACB | 0.20647082 |
| 140 | CAMK2D | 0.20392102 |
| 141 | KSR2 | 0.20385327 |
| 142 | TRPM7 | 0.20088468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.50161507 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.86603870 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.79819348 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.70308765 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.65358698 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.61806684 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.45477307 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.43554814 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26125356 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21490476 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.17129034 |
| 12 | Retinol metabolism_Homo sapiens_hsa00830 | 2.10935566 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.08352656 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.06379957 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06127658 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00160853 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.99553736 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99439986 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99391439 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.97143041 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.91208570 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.89796043 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.86152392 |
| 24 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.80785447 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76424238 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54502363 |
| 27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.44203276 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40051700 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39470269 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.36673669 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35201000 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33836593 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.32443690 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31890541 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.31093447 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29643032 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.28834109 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28435178 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27944771 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.24810576 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24515465 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.24321242 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23827456 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.18868057 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15964238 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.14204140 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.13996984 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 1.10960823 |
| 49 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.07572245 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06761084 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05575112 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04619015 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98778955 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97788486 |
| 55 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96613823 |
| 56 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.95176464 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.92286585 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91938157 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.91081461 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89987920 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89596131 |
| 62 | Insulin secretion_Homo sapiens_hsa04911 | 0.86689703 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84704152 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84271465 |
| 65 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83867388 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82747274 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.82475899 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82402980 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82093993 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80320633 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79407316 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.78659359 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78583862 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.78083166 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.77923989 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.77423014 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77130362 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76724851 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75566925 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.75262526 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.71323106 |
| 82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67269423 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.64791100 |
| 84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.62538086 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.61399150 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61211317 |
| 87 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60605453 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60067430 |
| 89 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58393198 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58210757 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.57768042 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56134620 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55080880 |
| 94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54851153 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53261589 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52912314 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52901559 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52072012 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.51872821 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51696296 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.51049535 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49747079 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48919127 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48363054 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48142587 |
| 106 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47415513 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47127693 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46932286 |
| 109 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45657963 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44877917 |
| 111 | Salivary secretion_Homo sapiens_hsa04970 | 0.44707172 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.44325825 |
| 113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43809626 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43765983 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43750636 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43297387 |
| 117 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42844769 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42828692 |
| 119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42403411 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42298668 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.41879781 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41603361 |
| 123 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41099813 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39185339 |
| 125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36665788 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.36247595 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35738808 |
| 128 | Pathways in cancer_Homo sapiens_hsa05200 | 0.35456020 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34881370 |
| 130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33960931 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32866660 |
| 132 | Axon guidance_Homo sapiens_hsa04360 | 0.32790036 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32774525 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32384028 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | 0.32189855 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31451351 |
| 137 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.30856491 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30823117 |
| 139 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.29967614 |
| 140 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29848665 |
| 141 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29279920 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29125304 |
| 143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28274925 |

